Deep Expertise for the Most Complex FDA Problems

Lassman Law+Policy

Lassman Law+Policy is a boutique law firm located in Washington, D.C. that focuses on solving its clients’ most complicated FDA-related problems. The firm works with sophisticated pharmaceutical, biotechnology, and medical device companies as well as investors and industry trade associations. Whether it is a cutting-edge exclusivity issue, a stalled approval program, or a biosimilar policy initiative, Lassman Law+Policy has the expertise and experience to resolve it. Scott Lassman is a recognized expert with nearly thirty years of experience in FDA law. In 2018, he was named one of the top five FDA regulatory attorneys in the United States.
Scott’s experience helps clients navigate the many legal gray areas they face, avoiding unseen dangers and taking advantage of hidden opportunities. Scott doesn’t just know the law, he knows the FDA — how it operates and how it interprets and enforces the law. Scott also is attuned to the special needs of corporate clients because he’s been one himself. In addition to his many years in private practice, Scott has worked in-house at both a mid-size drug company and a national trade association representing the innovative pharmaceutical industry. Because of this valuable experience, Scott seeks to provide practical solutions to his clients that focus, first and foremost, on achieving their business objectives. And he seeks to do so efficiently and on time.

Scott M. Lassman's Profile Image
Scott Lassman has nearly 30 years’ experience in FDA law and policy, both as an in-house attorney and in private practice. He provides strategic advice and advocacy to small, mid-size and large pharmaceutical, biotechnology and medical device companies, as well as the trade associations that represent them and the investors who fund them. His practice covers all aspects of FDA regulatory law, with a special focus on exclusivity, biosimilars, product approval and policy matters...
Read More About Scott

Recent Exclusivity Rules Posts

Scott M. Lassman recently was recognized again by The Best Lawyers in America as one of the leading lawyers in the United States in the categories of FDA Law and Administrative/Regulatory Law. Best Lawyers’ recognitions are based purely on the… Read More
It is very unusual for a Hatch-Waxman exclusivity issue to intersect with a Pixar movie. But a recent viewing of The Incredibles got me thinking about FDA’s 2016 final regulation regarding 180-day exclusivity, particularly its new rule that an ANDA… Read More
For many things in life, details matter. Take cooking, for instance: add the wrong ingredient or combine your ingredients in the wrong order, and you may have an unexpected disaster rather than a prize-winning pie. Trust me, you don’t want to eat a… Read More

Read More Recent Exclusivity Rules Posts